REDUCED FSH AND LH ACTION: IMPLICATIONS FOR MEDICALLY ASSISTED REPRODUCTION

Authors

  • Mominova Nodira Abdulxayevna Andijan State Medical Institute, Department of Pharmacology, Clinical Pharmacology, and Medical Biotechnology. Author

Keywords:

Keywords: This thesis utilizes a comprehensive review of molecular, genetic, and clinical trials to evaluate the biological determinants of impaired FSH and LH action.

Abstract

Folliculogenesis is tightly controlled by a complex neuroendocrine interaction among the hypothalamus, anterior pituitary gland, and ovaries, mediated by the synergistic actions of follicle-stimulating hormone (FSH) and luteinizing hormone (LH). Historically, gonadotropin-related subfertility was attributed primarily to deficient hormone production. However, contemporary evidence highlights that diminished gonadotropin action driven by advanced reproductive age, variable glycosylation, and receptor-level polymorphisms is a critical factor in reproductive failure. In medically assisted reproduction (MAR), the transient pituitary suppression induced by GnRH analogue protocols can compound this baseline resistance. This interaction culminates in unexpected ovarian hypo-responsiveness and suboptimal clinical outcomes, even in women with normal baseline ovarian reserves, necessitating innovative, highly targeted therapeutic modifications.

 

Downloads

Published

2026-09-23